The role of microRNAs in the pathogenesis of thyroid cancer

被引：41

作者：

Ghafouri-Fard, Soudeh ^{[1
]}

Shirvani-Farsani, Zeinab ^{[2
]}

Taheri, Mohammad ^{[3
]}

机构：

[1] Shahid Beheshti Univ Med Sci, Dept Med Genet, Tehran, Iran

[2] Shahid Beheshti Univ, GC, Fac Life Sci & Technol, Dept Cellular & Mol Biol, Tehran, Iran

[3] Shahid Beheshti Univ Med Sci, Urogenital Stem Cell Res Ctr, Tehran, Iran

来源：

NON-CODING RNA RESEARCH | 2020年 / 5卷 / 03期

关键词：

Thyroid cancer; miRNA; Biomarker; CELL-PROLIFERATION; INHIBITS PROLIFERATION; CARCINOMA; INVASION; GROWTH; MIGRATION; EXPRESSION; APOPTOSIS; TARGETS; SUPPRESSES;

D O I：

10.1016/j.ncrna.2020.06.001

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Thyroid cancer is the most frequent type of cancers originating from the endocrine system. Early diagnosis leads to good clinical outcome in differentiated types of thyroid cancer. Yet, there are few treatment options for patients with medullary or anaplastic thyroid cancer. Thus, identification of molecular markers that explain the pathologic process during evolution of this cancer has practical significance. MicroRNAs (miRNAs) have been shown to influence the activity of thyroid cancer-related signaling pathways such as MAPK pathway and RET gene. These small transcripts not only can differentiate malignant tissues from non-malignant tissues, but also have differential expression in different stages of thyroid cancer. Assessment of serum levels of miRNAs is a practical noninvasive method for follow-up of patients after thyroidectomy. Moreover, the therapeutic effects of a number of miRNAs have been verified in xenograft models of thyroid cancer. In the current review, we summarize the data regarding the role of miRNAs in thyroid cancer.

引用

页码：88 / 98

页数：11

共 73 条

[1]

[Anonymous], 2020, EXP MOL PATHOL

[2] MiR-150 Inhibits Cell Growth In Vitro and In Vivo by Restraining the RAB11A/WNT/β-Catenin Pathway in Thyroid Cancer [J].